Making complex cancer conversations clearer, calmer, and more human.
Featuring oncologists, researchers, advocates, caregivers, and survivors discussing the realities of modern cancer care with honesty, empathy, and clarity.
In this episode, we sit down with Jennifer R. Brown, MD, PhD, Dana-Farber Cancer Institute, Boston, MA, to unpack the AMPLIFY trial that is reshaping chronic lymphocytic leukemia (CLL) treatment. She explains how this new oral combination isn’t just effective but patient-friendly, cutting down on complexity and paving the way for more accessible care. Tune in to hear how this breakthrough is setting the stage for the future of CLL therapy.
